U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059832) titled 'Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors' on June 24.
Brief Summary: This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.
Study Start Date: April 01, 2024
Study Type: INTERVENTIONAL
Condition:
Cancer
Intervention:
DRUG: 68Ga-NODAGA-SNA006
68Ga-NODAGA-SNA006 PET/CT: after intravenous injection of 0.05 mCi/kg body weight of quality-controlled 68Ga-NODAGA-SNA006, an integrated PET/CT scanner (Biograph mCT; Siemens, Ger...